Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Influenza Vaccine Market Report by Vaccine Type (Quadrivalent, Trivalent), Technology (Egg-based, Cell-based), Age Group (Pediatric, Adult), Route of Administration (Injection, Nasal Spray), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A4206
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Influenza Vaccine Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Vaccine Type
6.1 Quadrivalent
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Trivalent
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Egg-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cell-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Age Group
8.1 Pediatric
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Adult
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Route of Administration
9.1 Injection
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Nasal Spray
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AstraZeneca plc
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 CSL Limited
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.3.4 SWOT Analysis
15.3.4 Daiichi Sankyo Company Limited
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Emergent BioSolutions Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 F. Hoffmann-La Roche AG
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.6.3 SWOT Analysis
15.3.7 Gamma Vaccines Pty Ltd
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 GlaxoSmithKline plc
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Merck & Co. Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Novartis AG
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.10.4 SWOT Analysis
15.3.11 Pfizer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Sanofi
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis
15.3.13 SINOVAC
15.3.13.1 Company Overview
15.3.13.2 Product Portfolio
15.3.13.3 Financials
List of Figures
Figure 1: Global: Influenza Vaccine Market: Major Drivers and Challenges
Figure 2: Global: Influenza Vaccine Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Influenza Vaccine Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Influenza Vaccine Market: Breakup by Vaccine Type (in %), 2023
Figure 5: Global: Influenza Vaccine Market: Breakup by Technology (in %), 2023
Figure 6: Global: Influenza Vaccine Market: Breakup by Age Group (in %), 2023
Figure 7: Global: Influenza Vaccine Market: Breakup by Route of Administration (in %), 2023
Figure 8: Global: Influenza Vaccine Market: Breakup by Region (in %), 2023
Figure 9: Global: Influenza Vaccine (Quadrivalent) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Influenza Vaccine (Quadrivalent) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Influenza Vaccine (Trivalent) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Influenza Vaccine (Trivalent) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Influenza Vaccine (Egg-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Influenza Vaccine (Egg-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Influenza Vaccine (Cell-based) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Influenza Vaccine (Cell-based) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Influenza Vaccine (Pediatric) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Influenza Vaccine (Pediatric) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Influenza Vaccine (Adult) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Influenza Vaccine (Adult) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Influenza Vaccine (Injection) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Influenza Vaccine (Injection) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Influenza Vaccine (Nasal Spray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Influenza Vaccine (Nasal Spray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: North America: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: North America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: United States: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: United States: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Canada: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Canada: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Asia-Pacific: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Asia-Pacific: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: China: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: China: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Japan: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Japan: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: India: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: India: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: South Korea: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: South Korea: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Australia: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Australia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Indonesia: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Indonesia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Europe: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Europe: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Germany: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Germany: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: France: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: France: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: United Kingdom: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: United Kingdom: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Italy: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Italy: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Spain: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Spain: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Russia: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Russia: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Latin America: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Latin America: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Brazil: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Brazil: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Mexico: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Mexico: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Others: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Others: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Middle East and Africa: Influenza Vaccine Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Middle East and Africa: Influenza Vaccine Market: Breakup by Country (in %), 2023
Figure 73: Middle East and Africa: Influenza Vaccine Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Global: Influenza Vaccine Industry: SWOT Analysis
Figure 75: Global: Influenza Vaccine Industry: Value Chain Analysis
Figure 76: Global: Influenza Vaccine Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Influenza Vaccine Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Influenza Vaccine Market Forecast: Breakup by Vaccine Type (in Million US$), 2024-2032
Table 3: Global: Influenza Vaccine Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 4: Global: Influenza Vaccine Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 5: Global: Influenza Vaccine Market Forecast: Breakup by Route of Administration (in Million US$), 2024-2032
Table 6: Global: Influenza Vaccine Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Influenza Vaccine Market: Competitive Structure
Table 8: Global: Influenza Vaccine Market: Key Players
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More